Log in

Relevant bibliographies by topics / Healthline / Journal articles

To see the other types of publications on this topic, follow the link: Healthline.

Journal articles on the topic 'Healthline'

Author: Grafiati

Published: 13 December 2022

Last updated: 27 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Healthline.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Nataraj, Jonathon, James Stempien, Stuart Netherton, Mark Yosri Wahba, and Taofiq Olusegun Oyedokun. "Emergency department referrals from a provincial medical call centre: Is it more than just 1-800-go-to-emerg?" CJEM 22, no. 2 (2019): 241–44. http://dx.doi.org/10.1017/cem.2019.420.

Full text

Abstract:

ABSTRACTObjectiveHealthLine is Saskatchewan's provincial 24-hour health information and support telephone line. A proportion of HealthLine's callers are referred to the emergency department (ED) for further assessment. The purpose of this study was to gain insight into the appropriateness of these referrals and assess whether they increased the burden on an already strained ED system.MethodsA list of callers referred from HealthLine to Saskatoon EDs from January 1, 2014, to March 31, 2014 was obtained. This list was cross-referenced with Saskatoon Health Region registration data to determine which of those callers had been registered in one of the three Saskatoon EDs within 48 hours of the original call.ResultsDuring the 90-day time period in question, 707/3,938 (17.9%) of callers were referred by HealthLine to the ED. Out of those referred, 601 were identifiable and 358 attended the ED. Hospital charts were pulled for full data extraction and analysis of the 276 who met inclusion criteria. Of those who presented to the ED and met inclusion criteria, 60% had investigations performed while 66% received some form of treatment. The overall admission rate for the patient population studied was 12.0% v. 16% for non-referred patients. Referred pediatric patients had fewer investigations and treatments with a lower admission rate compared with the adult patients.ConclusionThe Saskatchewan HealthLine is doing an effective job at directing callers both to and away from EDs in Saskatoon and not overburdening our local EDs with unnecessary referrals.

APA, Harvard, Vancouver, ISO, and other styles

2

Gillespie, Yvonne, Ian St George, and Davis Lemke. "Men Calling Healthline." Telemedicine and e-Health 19, no. 1 (2013): 42–47. http://dx.doi.org/10.1089/tmj.2012.0028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Jarrell, Brett, Allison Tadros, Charles Whiteman, Todd Crocco, and Stephen M. Davis. "National Healthline Responses to a Stroke Scenario." Stroke 38, no. 8 (2007): 2376–78. http://dx.doi.org/10.1161/strokeaha.107.487710.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

RIGGE, MARIANNE. "'Healthline': a new service from the College of Health." Health Libraries Review 3, no. 1 (1986): 1–10. http://dx.doi.org/10.1046/j.1365-2532.1986.310001.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Geddes, Lesley, and Ian Watt. "Hull Healthline: A Description of a Telephone Health Information and Promotion Service." Journal of the Royal Society of Health 113, no. 4 (1993): 187–89. http://dx.doi.org/10.1177/146642409311300408.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Glueckauf, Robert L., Curtis Stine, Michelle Bourgeois, et al. "Alzheimer's Rural Care Healthline: Linking Rural Caregivers to Cognitive-Behavioral Intervention for Depression." Rehabilitation Psychology 50, no. 4 (2005): 346–54. http://dx.doi.org/10.1037/0090-5550.50.4.346.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Haidar, Hamida, Syed Kazim Shah, and Alina Awan. "A CRITICAL DISCOURSE ANALYSIS OF MEDICAL ASSOCIATIONS AND RESEARCH JOURNALS ON OBESITY USING VAN DIJK’S MODEL." Inception - Journal of Languages and Literature 1, no. 2 (2021): 1–17. http://dx.doi.org/10.36755/ijll.v1i2.31.

Full text

Abstract:

The present study aims at exploring the CDA approach to determine the differences in the discourse of research articles in medical journals and associations. The study investigates how the associations delete, select, construct or generalize information for their benefits. The information was gathered from medical research articles and associations about obesity. World Health Organization (WHO), Obesity Medicine Association (OMA), National Institutes of Health (NIH), National Health Services (NHS), Healthline, Mayo Clinic are among the organizations that have been chosen for this study. The macro structure of Van Dijk model is used to address the research questions and to determine whether medical journals and associations are on the same page or not. As a result, associations have more authority than journals. The results of this descriptive self-study are summarized in graph charts and tables.

APA, Harvard, Vancouver, ISO, and other styles

8

Harding, Jean. "An evaluation of the costs and effectiveness of different methods used to publicize a telephone Healthline." Health Libraries Review 13, no. 2 (1996): 114–17. http://dx.doi.org/10.1046/j.1365-2532.1996.13201093.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Navratil-Strawn, Jessica L., Kevin Hawkins, Stephen K. Hartley, et al. "Using Propensity to Succeed Modeling to Increase Utilization and Adherence in a Nurse HealthLine Telephone Triage Program." Journal of Ambulatory Care Management 39, no. 3 (2016): 186–98. http://dx.doi.org/10.1097/jac.0000000000000103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Griffin, Edward, John P. McCarthy, Fiona Thomas, and Simon Kingham. "New Zealand Healthline call data used to measure the effect of travel time on the use of the emergency department." Social Science & Medicine 179 (April 2017): 91–96. http://dx.doi.org/10.1016/j.socscimed.2017.02.035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Coggan, Janet M. "HealthLink Plus." Health Care on the Internet 5, no. 3 (2001): 69–72. http://dx.doi.org/10.1300/j138v05n03_07.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Hauser, Ross A., Johanna B. Lackner, Danielle Steilen-Matias, and David K. Harris. "A Systematic Review of Dextrose Prolotherapy for Chronic Musculoskeletal Pain." Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 9 (January 2016): CMAMD.S39160. http://dx.doi.org/10.4137/cmamd.s39160.

Full text

Abstract:

Objective The aim of this study was to systematically review dextrose (D-glucose) prolotherapy efficacy in the treatment of chronic musculoskeletal pain. Data Sources Electronic databases PubMed, Healthline, OmniMedicalSearch, Medscape, and EMBASE were searched from 1990 to January 2016. Study Selection Prospectively designed studies that used dextrose as the sole active prolotherapy constituent were selected. Data Extraction Two independent reviewers rated studies for quality of evidence using the Physiotherapy Evidence Database assessment scale for randomized controlled trials (RCTs) and the Downs and Black evaluation tool for non-RCTs, for level of evidence using a modified Sackett scale, and for clinically relevant pain score difference using minimal clinically important change criteria. Study population, methods, and results data were extracted and tabulated. Data Synthesis Fourteen RCTs, 1 case–control study, and 18 case series studies met the inclusion criteria and were evaluated. Pain conditions were clustered into tendinopathies, osteoarthritis (OA), spinal/pelvic, and myofascial pain. The RCTs were high-quality Level 1 evidence (Physiotherapy Evidence Database ≥8) and found dextrose injection superior to controls in Osgood–Schlatter disease, lateral epicondylitis of the elbow, traumatic rotator cuff injury, knee OA, finger OA, and myofascial pain; in biomechanical but not subjective measures in temporal mandibular joint; and comparable in a short-term RCT but superior in a long-term RCT in low back pain. Many observational studies were of high quality and reported consistent positive evidence in multiple studies of tendinopathies, knee OA, sacroiliac pain, and iliac crest pain that received RCT confirmation in separate studies. Eighteen studies combined patient self-rating (subjective) with psychometric, imaging, and/or biomechanical (objective) outcome measurement and found both positive subjective and objective outcomes in 16 studies and positive objective but not subjective outcomes in two studies. All 15 studies solely using subjective or psychometric measures reported positive findings. Conclusion Use of dextrose prolotherapy is supported for treatment of tendinopathies, knee and finger joint OA, and spinal/pelvic pain due to ligament dysfunction. Efficacy in acute pain, as first-line therapy, and in myofascial pain cannot be determined from the literature.

APA, Harvard, Vancouver, ISO, and other styles

13

Pauline, Lillistone, Chappell Rachel, Dukes Charlie, Higenbottam David, and Kipps Christopher. "WED 273 Wessex healthlines: neuroline." Journal of Neurology, Neurosurgery & Psychiatry 89, no. 10 (2018): A39.4—A40. http://dx.doi.org/10.1136/jnnp-2018-abn.137.

Full text

Abstract:

BackgroundThe ability to provide timely signposting to patient with neurological conditions seen in clinic is crucial, but information resources are not always available or updated. Individuals wishing to participate in clinical trials may find it difficult to locate research opportunities, and busy clinicians may not be aware of local clinical research studies. We sought to develop a means of collating, organizing and displaying information on neurological conditions and research trials in an easily accessible form online.MethodsOver 350 local support groups, information resources and websites dealing with neurological conditions relevant to neurological patients in Wessex were identified. These were then displayed via a website that maps these resources, and offers a summary with a link to the primary source.ResultsOver the past year, the Wessex HealthLines site has been visited by over 2300 users, with the NeuroLine pages (wessexhealthlines.nhs.uk/neuroline) accessed by over 750 users. The site has now been expanded to include neurological research trials running in the region (ResearchLine).DiscussionThe Wessex HealthLines website (NeuroLine, ResearchLine) makes use of multiple resources to support information signposting in neurological conditions, and to clinical trials, across Wessex. Other regions interested in quality improvement projects may find this approach useful.

APA, Harvard, Vancouver, ISO, and other styles

14

Roos, Johannes L. "Genetic and family counselling for schizophrenia: Where do we stand now?" South African Journal of Psychiatry 22, no. 1 (2016): 6. http://dx.doi.org/10.4102/sajpsychiatry.v22i1.831.

Full text

Abstract:

<p><strong>Background:</strong> Recent genetic findings have led to profound changes in genetic and family counselling for schizophrenia patients and their families.</p><p><strong>Objectives:</strong> The article gives an overview of the present knowledge regarding the genetic and family counselling for schizophrenia.</p><p><strong>Method:</strong> Literature searches were performed on the MEDLINE database (2011–2015) and African Healthline. A current alert service which provides the most recent literature on the topic on a monthly basis was also used in the study. A clinical case example is presented as is experienced in daily psychiatric practice.</p><p><strong>Results:</strong> Genetic risk communication has become the responsibility of the multiprofessional treatment team, moving away from specialists in the field. The treatment team provides information on a daily basis regarding risk predictors in the management of schizophrenia, including risk of relapse, suicide and comorbid substance use. Although genetic information is unique and has implications for blood relatives, genetic risk factors only rarely provide information that is inherently different from that provided by other risk predictors commonly used in healthcare. The common variant common disease and rare variant common disease models as contrasting hypothesis of the genetics of schizophrenia are discussed and debated. An example of a family counselled is given and the place of commercial companies that offer directly to the consumer affordable personal DNA testing for psychiatric illness is discussed. Ethical issues without resolution regarding genetic counselling of schizophrenia are debated.</p><p><strong>Conclusions:</strong> Recent genetic findings must lead to profound changes in genetic and family counselling in schizophrenia. Exposed attributable risk has immediate effects on genetic counselling of schizophrenia. Psychiatric risk counselling has thus changed from risk estimates based on family history to estimates based on test results in specific individuals.</p><p><strong><br /></strong></p>

APA, Harvard, Vancouver, ISO, and other styles

15

Hammond, Sarah, and Victoria Richardson. "Keeping information alive: resource centres for district level health workers in Tanzania." African Research & Documentation 93 (2003): 19–21. http://dx.doi.org/10.1017/s0305862x00017787.

Full text

Abstract:

Healthlink Worldwide is an international NGO (www.healthlink.org.uk), working with partners in Africa, Asia, the Middle East and Latin America to improve the use and impact of health information and health communications in poor and vulnerable communities. Over the last twenty-five years, Healthlink Worldwide has developed expertise in resource centre development, which is now co-ordinated through Source (www.asksource.info). A collaborative venture of Healthlink Worldwide, the Centre for International Child Health and Handicap International, Source is an international information support centre designed to strengthen the management, use and impact of information on health and disability.The Source model brings together good practice in information management, capacity development in partnership with organisations in developing countries, and a unique collection of resources and integrated methods for communication around health. Source identifies, reviews, and signposts materials produced by, or appropriate to, developing country users, particularly ‘good practice’ in the field, and reflects the priorities of developing country information needs in its services and systems.

APA, Harvard, Vancouver, ISO, and other styles

16

Weiss, Marisa C., Julianne Hibbs, Terri W. McHugh, et al. "A survey of breast cancer patients’ use of cannabis before, during, and after treatment." Journal of Clinical Oncology 38, no. 15_suppl (2020): e19210-e19210. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e19210.

Full text

Abstract:

e19210 Background: The availability of cannabis is rapidly expanding and cancer is a qualifying condition in all states allowing medical cannabis. However, there are many unknowns with respect to patterns of cannabis use among breast cancer patients. The goal of this study was to better understand how and when cannabis is used among breast cancer patients. Methods: Between 12/16/2019 and 1/19/2020, U.S.-based members of Breastcancer.org and the Healthline communities were invited to participate in a cannabis survey. Subjects confirmed they were age ≥18 and diagnosed with breast cancer within 5 years. After informed consent, data were collected, de-identified and analyzed in aggregate. The study was led by Socanna, conducted by Outcomes Insights, and supported by a grant from Ananda Health/Ecofibre. Results: A total of 3522 persons initiated screening, 832 completed screening, and 725 met eligibility criteria, of whom 612 completed the survey (84%). The results showed that 42% of participants had used medical cannabis products to relieve symptoms, including insomnia (70%), pain (59%), anxiety (57%), stress (51%), and nausea/vomiting (46%). Additionally, cannabis was used prior to treatment in 24%, during treatment in 79%, and after treatment in 54%. Of subjects reporting cannabis use during treatment: 86% used it during chemotherapy, 71% during HER2 therapy, 65% during hormonal therapy, 49% during breast radiation, and 47% during radiation for metastatic sites. Post-surgical use was reported in 51% after mastectomy alone, 40% after lumpectomy, and 38% after mastectomy/reconstruction. An average of 3-4 cannabis products were utilized. Products were sourced from medical dispensaries (54%), family/friends (33%), and recreational sources (27%). Although cannabis using subjects strongly preferred medical sources, 77% had also utilized recreational sources. Conclusions: This survey shows that almost half of breast cancer patients reported using cannabis to help relieve common symptoms from breast cancer or its treatments. Of those, 79% used cannabis during active treatment, which can impact efficacy and safety. To date, studies have not investigated drug interactions between cannabis and these therapeutic agents. Furthermore, there is a concern regarding contaminants. Although most medical cannabis is tested for pathogens and contaminants, this is not the case for cannabis obtained from other sources. The results of this study highlight the need for research regarding cannabis for medical purposes, including safety and interaction studies.

APA, Harvard, Vancouver, ISO, and other styles

17

Weiss, Marisa C., Meghan Buckley, Julianne Hibbs, et al. "A survey of cannabis use for symptom palliation in breast cancer patients by age and stage." Journal of Clinical Oncology 38, no. 15_suppl (2020): 12108. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.12108.

Full text

Abstract:

12108 Background: Most US states have legalized medical cannabis for the treatment of serious conditions, including cancer. It is not well known which symptoms breast cancer patients seek to control with cannabis. Methods: Members of the Breastcancer.org and Healthline communities were invited to participate in this survey between 12/16/2019 and 1/19/2020. Eligibility criteria included age ≥18 years, resident of the US and a breast cancer diagnosis within the past 5 years. Eligible respondent data were analyzed for the symptomatic profile of cannabis users. Symptoms were compared between two groups using a Chi-square test of independence. The survey was led by Socanna, conducted by Outcomes Insights, and supported by a grant from Ananda Health/Ecofibre. Results: Among the 832 respondents who completed screening, 725 met the eligibility criteria, and 612 (84%) completed the survey. The median age of respondents was 57 years, and 85% had non-metastatic disease An estimated 42% of respondents have used medical cannabis to treat symptoms or side effects of breast cancer. Medical cannabis users reported using cannabis to treat insomnia (70%), joint and muscle aches, discomfort, stiffness, or pain (59%), anxiety (57%), and stress (51%). The medical cannabis users less than 50-year-old were more likely to use cannabis to treat these symptoms than their over 50-year-old counterparts, however, the differences were not statistically significant. Medical cannabis users under age 50 used cannabis significantly more than over 50 to treat nausea/vomiting (58% vs 40%; p = 0.010) and inflammation (34% vs 20%; p = 0.021). Medical cannabis users with metastatic disease were more likely to use medical cannabis to treat chronic pain 60% vs 41%; p = 0.017) than non-metastatic users. Post-surgery patients were most likely to use cannabis for nerve pain; and those who were beyond treatment, for stress. Patients suffered an average of 5 symptoms. Conclusions: A significant proportion of breast cancer patients reported using cannabis to treat a combination of symptoms from their cancer and its treatment. Although younger patients are somewhat more likely to use this form of palliative management, older patients are suffering from the same symptoms and their use is nearly as high. More research is needed on the personalization of safe and effective symptomatic management with medical cannabis, for people of all ages, stages, and forms of treatment.

APA, Harvard, Vancouver, ISO, and other styles

18

Myers, Glenda, Thokozile Nkabinde, and Duane Blaauw. "HealthLink: SatelLife and HealthNet in South Africa." Electronic Library 13, no. 4 (1995): 293–98. http://dx.doi.org/10.1108/eb045378.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Salisbury, Chris, Alicia O’Cathain, Clare Thomas, et al. "An evidence-based approach to the use of telehealth in long-term health conditions: development of an intervention and evaluation through pragmatic randomised controlled trials in patients with depression or raised cardiovascular risk." Programme Grants for Applied Research 5, no. 1 (2017): 1–468. http://dx.doi.org/10.3310/pgfar05010.

Full text

Abstract:

BackgroundHealth services internationally are exploring the potential of telehealth to support the management of the growing number of people with long-term conditions (LTCs).AimTo develop, implement and evaluate new care programmes for patients with LTCs, focusing on two common LTCs as exemplars: depression or high cardiovascular disease (CVD) risk.MethodsDevelopmentWe synthesised quantitative and qualitative evidence on the effectiveness of telehealth for LTCs, conducted a qualitative study based on interviews with patients and staff and undertook a postal survey to explore which patients are interested in different forms of telehealth. Based on these studies we developed a conceptual model [TElehealth in CHronic disease (TECH) model] as a framework for the development and evaluation of the Healthlines Service for patients with LTCs.ImplementationThe Healthlines Service consisted of regular telephone calls to participants from health information advisors, supporting them to make behaviour change and to use tailored online resources. Advisors sought to optimise participants’ medication and to improve adherence.EvaluationThe Healthlines Service was evaluated with linked pragmatic randomised controlled trials comparing the Healthlines Service plus usual care with usual care alone, with nested process and economic evaluations. Participants were adults with depression or raised CVD risk recruited from 43 general practices in three areas of England. The primary outcome was response to treatment and the secondary outcomes included anxiety (depression trial), individual risk factors (CVD risk trial), self-management skills, medication adherence, perceptions of support, access to health care and satisfaction with treatment.Trial resultsDepression trialIn total, 609 participants were randomised and the retention rate was 86%. Response to treatment [Patient Health Questionnaire 9-items (PHQ-9) reduction of ≥ 5 points and score of < 10 after 4 months] was higher in the intervention group (27%, 68/255) than in the control group (19%, 50/270) [odds ratio 1.7, 95% confidence interval (CI) 1.1 to 2.5;p = 0.02]. Anxiety also improved. Intervention participants reported better access to health support, greater satisfaction with treatment and small improvements in self-management, but not improved medication adherence.CVD risk trialIn total, 641 participants were randomised and the retention rate was 91%. Response to treatment (maintenance of/reduction in QRISK®2 score after 12 months) was higher in the intervention group (50%, 148/295) than in the control group (43%, 124/291), which does not exclude a null effect (odds ratio 1.3, 95% CI 1.0 to 1.9;p = 0.08). The intervention was associated with small improvements in blood pressure and weight, but not smoking or cholesterol. Intervention participants were more likely to adhere to medication, reported better access to health support and greater satisfaction with treatment, but few improvements in self-management.The Healthlines Service was likely to be cost-effective for CVD risk, particularly if the benefits are sustained, but not for depression. The intervention was implemented largely as planned, although initial delays and later disruption to delivery because of the closure of NHS Direct may have adversely affected participant engagement.ConclusionThe Healthlines Service, designed using an evidence-based conceptual model, provided modest health benefits and participants valued the better access to care and extra support provided. This service was cost-effective for CVD risk but not depression. These findings of small benefits at extra cost are consistent with previous pragmatic research on the implementation of comprehensive telehealth programmes for LTCs.Trial registrationCurrent Controlled Trials ISRCTN14172341 (depression trial) and ISRCTN27508731 (CVD risk trial).FundingThe National Institute for Health Research Programme Grants for Applied Research programme.

APA, Harvard, Vancouver, ISO, and other styles

20

Westra, Brian. "HealthLinks: A ColdFusion Web Application." Internet Reference Services Quarterly 7, no. 1-2 (2002): 63–88. http://dx.doi.org/10.1300/j136v07n01_05.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Hammerback, Kristen, Peggy A. Hannon, Amanda T. Parrish, Claire Allen, Marlana J. Kohn, and Jeffrey R. Harris. "Comparing Strategies for Recruiting Small, Low-Wage Worksites for Community-Based Health Promotion Research." Health Education & Behavior 45, no. 5 (2018): 690–96. http://dx.doi.org/10.1177/1090198118769360.

Full text

Abstract:

Background. HealthLinks is a workplace health promotion program developed in partnership with the American Cancer Society. It delivers a package of evidence-based interventions and implementation support to small worksites in low-wage industries. As part of a randomized, controlled trial of HealthLinks, we studied approaches to recruiting these worksites. Aims. This study aims to guide future recruitment for community-based worksite health promotion interventions by comparing three approaches, including leveraging relationships with community partners. Method. We recruited 78 small, low-wage worksites in King County, Washington, to participate in the trial via three approaches: phone calls to companies on a purchased list (“cold”), phone calls to a list of eligible companies provided by a health insurer (“lukewarm”), and personal referrals from local health insurers and brokers (“warm”). Eligible and interested worksites received an in-person visit from researchers and completed additional steps to enroll. Results. Of the worksites screened and deemed eligible, 32% of the “cold” worksites enrolled in HealthLinks, as did 48% and 60%, respectively, of the “lukewarm” and “warm” worksites. Compared with “warm” worksites, “cold” worksites were twice as likely to be ineligible. Discussion. Two distinct factors help explain why “warmer” worksites were more likely to enroll in HealthLinks. First, eligibility was significantly higher among warmer referrals. Second, most of the warm-referred worksites eligible for the study agreed to meet in person with the project team to hear more about the project. Conclusions. “Warmer” recruitment approaches yielded higher recruitment. Leveraging relationships with community partners can help researchers identify and successfully recruit small, low-wage worksites.

APA, Harvard, Vancouver, ISO, and other styles

22

Zhang, Jin, and Dietmar Wolfram. "Visual analysis of obesity‐related query terms on HealthLink." Online Information Review 33, no. 1 (2009): 43–57. http://dx.doi.org/10.1108/14684520910944382.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Sneha, Sweta, Srivarun Thalla, Ishaan Rischie, and Hossain Shahriar. "Health Internet Technology for Chronic Conditions: Review of Diabetes Management Apps." JMIR Diabetes 6, no. 3 (2021): e17431. http://dx.doi.org/10.2196/17431.

Full text

Abstract:

Background Mobile health (mHealth) smartphone apps have shown promise in the self-management of chronic disease. In today’s oversaturated health app market, selection criteria that consumers are employing to choose mHealth apps for disease self-management are of paramount importance. App quality is critical in monitoring disease controls but is often linked to consumer popularity rather than clinical recommendations of effectiveness in disease management. Management of key disease variances can be performed through these apps to increase patient engagement in disease self-management. This paper provides a comprehensive review of features found in mHealth apps frequently used in the self- management of diabetes. Objective The purpose of this study was to review features of frequently used and high consumer-rated mHealth apps used in the self-management of diabetes. This study aimed to highlight key features of consumer-favored mHealth apps used in the self-management of diabetes. Methods A 2-fold approach was adopted involving the Apple iOS store and the Google search engine. The primary search was conducted on the Apple iOS store using the term “diabetes apps” (device used: Apple iPad). The top 5 most frequently used mHealth apps were identified and rated by the number of consumer reviews, app ratings, and the presence of key diabetes management features, such as dietary blood glucose, A1C, insulin, physical activity, and prescription medication. A subsequent Google search was conducted using the search term “best Apple diabetes apps.” The top 3 search results—“Healthline,” “Everyday Health,” and “Diabetes Apps–American Diabetes Association”—were explored. Results In total, 12 mHealth apps were reviewed due to their appearing across 4 evaluated sources. Only 1 health app—Glucose Buddy Diabetes Tracker—appeared as the most frequently used within the Apple iOS store and across the other 3 sources. The OneTouch Reveal app ranked first on the list in the iOS store with 39,000 consumer reviews and a rating of 4.7 out of 5.0 stars but only appeared in 1 of the other 3 sources. Blood glucose tracking was present across all apps, but other disease management features varied in type with at least 3 of the 5 key features being present across the 12 reviewed apps. Subscription cost and integration needs were present in the apps which could impact consumers’ decision to select apps. Although mobile app preference was assessed and defined by the number of consumer reviews and star ratings, there were no scientific standards used in the selection and ranking of the health apps within this study. Conclusions mHealth apps have shown promise in chronic disease management, but a surge in development of these nonregulated health solutions points to a need for regulation, standardization, and quality control. A governing body of health IT professionals, clinicians, policymakers, payors, and patients could be beneficial in defining health app standards for effective chronic disease management. Variabilities in features, cost, and other aspects of management could be reduced by regulatory uniformity, which would increase patient engagement and improve disease outcomes.

APA, Harvard, Vancouver, ISO, and other styles

24

Hutchinson, J. F. "The Junior Red Cross goes to Healthland." American Journal of Public Health 87, no. 11 (1997): 1816–23. http://dx.doi.org/10.2105/ajph.87.11.1816.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Yasnoff, William A. "US HealthLink: A national information resource for health care professionals." Journal of Medical Systems 16, no. 2-3 (1992): 95–100. http://dx.doi.org/10.1007/bf00996590.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Yeung, Matthew, Kevin Janz, Colin Weaver, Rebecca Saah-Haines, and Eddy Lang. "Cannabis in the Emergency Department: The impact of cannabis legalization on cannabis and opioid-related presentations." Alberta Academic Review 2, no. 3 (2019): 6. http://dx.doi.org/10.29173/aar93.

Full text

Abstract:

Background: On October 17th, 2018, non-medical cannabis became legal to adults for the first time in Canada. This has created a previously unseen opportunity to investigate the effects of recreational cannabis legalization in a developed country, particularly on strained Emergency Departments (EDs). Secondly, reports within the United States have suggested state-level legalization of cannabis, both recreationally and medically, has resulted in a decrease of opiate-related presentations. Given the pressure of the opiate crisis on healthcare resources, we sought to examine if this trend was present in Alberta. Objectives: The current study aims to identify if presentation patterns in adult and pediatric populations have changed when comparing pre- and post-legalization periods, and if rural-urban disparities exist. We also aim to identify if the legalization of cannabis is correlated with a reduction in opiate-related ED presentations. Lastly, we aimed to address the aforementioned objectives in the context of telehealth by examining calls to poison control and HealthLink within Alberta. Methods: Retrospective data was collected from the National Ambulatory Care Reporting System, HealthLink, and Poison and Drug Information Service. Extraction is currently in progress, and we expect to include 20 000 records and 12 000 calls. An interrupted time-series analysis will be completed, allowing for a comparison of trends pre- and post-legalization. Participants have been identified based on International Disease Classifications for cannabis and opiate-related injury. Commonly reported injuries will be clustered to identify changes in injury patterns. Data was collected from October 1st 2013 up to May 31st, 2019 for all EDs within Alberta. Results: Preliminary results suggest the legalization of cannabis initially led to a dramatic increase in ED presentations, followed by a return to pre-legalization volume. HealthLink data suggests a different trend, with steadily increasing calls in the months prior to legalization, followed by stabilization. Cannabis legalization is also correlated with a decrease in post-legalization opiate-related calls (r=-0.51, p=0.01). Conclusion: Overall, national legalization of cannabis appears to be responsible for a short period of increased ED usage, but does not appear to have long-lasting effects on healthcare resource utilization. Differences are apparent between telehealth service and ED use.

APA, Harvard, Vancouver, ISO, and other styles

27

MacLeod, Donna. "Healthlink BC: British Columbians Have Trusted Health Information at Their Fingertips." Journal of Consumer Health On the Internet 13, no. 2 (2009): 173–79. http://dx.doi.org/10.1080/15398280902897046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Ferrier, Denise, Frances Diver, Simone Corin, Peter McNair, and Choon Cheng. "HealthLinks: Incentivising better value chronic care in Victoria." International Journal of Integrated Care 17, no. 3 (2017): 129. http://dx.doi.org/10.5334/ijic.3241.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Hannon, Peggy A., Kristen Hammerback, Claire L. Allen, et al. "HealthLinks randomized controlled trial: Design and baseline results." Contemporary Clinical Trials 48 (May 2016): 1–11. http://dx.doi.org/10.1016/j.cct.2016.02.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Dixon, Padraig, Sandra Hollinghurst, Louisa Edwards, et al. "Cost-effectiveness of telehealth for patients with depression: evidence from the Healthlines randomised controlled trial." BJPsych Open 2, no. 4 (2016): 262–69. http://dx.doi.org/10.1192/bjpo.bp.116.002907.

Full text

Abstract:

BackgroundDepression is a prevalent long-term condition that is associated with substantial resource use. Telehealth may offer a cost-effective means of supporting the management of people with depression.AimsTo investigate the cost-effectiveness of a telehealth intervention (‘Healthlines’) for patients with depression.MethodA prospective patient-level economic evaluation conducted alongside a randomised controlled trial. Patients were recruited through primary care, and the intervention was delivered via a telehealth service. Participants with a confirmed diagnosis of depression and PHQ-9 score ≥10 were recruited from 43 English general practices. A series of up to 10 scripted, theory-led, telephone encounters with health information advisers supported participants to effect a behaviour change, use online resources, optimise medication and improve adherence. The intervention was delivered alongside usual care and was designed to support rather than duplicate primary care. Cost-effectiveness from a combined health and social care perspective was measured by net monetary benefit at the end of 12 months of follow-up, calculated from incremental cost and incremental quality-adjusted life years (QALYs). Cost–consequence analysis included cost of lost productivity, participant out-of-pocket expenditure and the clinical outcome.ResultsA total of 609 participants were randomised – 307 to receive the Healthlines intervention plus usual care and 302 to receive usual care alone. Forty-five per cent of participants had missing quality of life data, 41% had missing cost data and 51% of participants had missing data on either cost or utility, or both. Multiple imputation was used for the base-case analysis. The intervention was associated with incremental mean per-patient National Health Service/personal social services cost of £168 (95% CI £43 to £294) and an incremental QALY gain of 0.001 (95% CI −0.023 to 0.026). The incremental cost-effectiveness ratio was £132 630. Net monetary benefit at a cost-effectiveness threshold of £20 000 was –£143 (95% CI –£164 to –£122) and the probability of the intervention being cost-effective at this threshold value was 0.30. Productivity costs were higher in the intervention arm, but out-of-pocket expenses were lower.ConclusionsThe Healthlines service was acceptable to patients as a means of condition management, and response to treatment after 4 months was higher for participants randomised to the intervention. However, the positive average intervention effect size was modest, and incremental costs were high relative to a small incremental QALY gain at 12 months. The intervention is not likely to be cost-effective in its current form.

APA, Harvard, Vancouver, ISO, and other styles

31

Tanarte, Antonette. "Western Healthlinks – Implementation of a Priority Assessment Service within Health Navigation." International Journal of Integrated Care 20, no. 3 (2021): 184. http://dx.doi.org/10.5334/ijic.s4184.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Brown, Meagan C., Jeffrey R. Harris, Kristen Hammerback, et al. "Development of a Wellness Committee Implementation Index for Workplace Health Promotion Programs in Small Businesses." American Journal of Health Promotion 34, no. 6 (2020): 614–21. http://dx.doi.org/10.1177/0890117120906967.

Full text

Abstract:

Purpose: To construct a wellness committee (WC) implementation index and determine whether this index was associated with evidence-based intervention implementation in a workplace health promotion program. Design: Secondary data analysis of the HealthLinks randomized controlled trial. Setting: Small businesses assigned to the HealthLinks plus WC study arm. Sample: Small businesses (20-200 employees, n = 23) from 6 low-wage industries in King County, Washington. Measures: Wellness committee implementation index (0%-100%) and evidence-based intervention implementation (0%-100%). Analysis: We used descriptive and bivariate statistics to describe worksites’ organizational characteristics. For the primary analyses, we used generalized estimating equations with robust standard errors to assess the association between WC implementation index and evidence-based intervention implementation over time. Results: Average WC implementation index scores were 60% at 15 months and 38% at 24 months. Evidence-based intervention scores among worksites with WCs were 27% points higher at 15 months (64% vs 37%, P < .001) and 36% points higher at 24 months (55% vs 18%, P < .001). Higher WC implementation index scores were positively associated with evidence-based intervention implementation scores over time ( P < .001). Conclusion: Wellness committees may play an essential role in supporting evidence-based intervention implementation among small businesses. Furthermore, the degree to which these WCs are engaged and have leadership support, a set plan or goals, and multilevel participation may influence evidence-based intervention implementation and maintenance over time.

APA, Harvard, Vancouver, ISO, and other styles

33

Sweet, Kevin, Amy C. Sturm, Amy Rettig, Joseph McElroy, and Doreen Agnese. "Clinically relevant lessons from Family HealthLink: a cancer and coronary heart disease familial risk assessment tool." Genetics in Medicine 17, no. 6 (2014): 493–500. http://dx.doi.org/10.1038/gim.2014.136.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Barnes, Kirsty, Craig Nelson, Julia Jones, Jason Plat, and Russell Harrison. "Western Health Healthlinks improves acute hospital utilisation in patients with chronic and complex conditions." International Journal of Integrated Care 20, no. 3 (2021): 34. http://dx.doi.org/10.5334/ijic.s4034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Bullock, James M., and Robin J. Pakeman. "Grazing of lowland heath in England: Management methods and their effects on healthland vegetation." Biological Conservation 79, no. 1 (1997): 1–13. http://dx.doi.org/10.1016/s0006-3207(96)00117-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Dixon, Padraig, Sandra Hollinghurst, Louisa Edwards, et al. "Cost-effectiveness of telehealth for patients with raised cardiovascular disease risk: evidence from the Healthlines randomised controlled trial." BMJ Open 6, no. 8 (2016): e012352. http://dx.doi.org/10.1136/bmjopen-2016-012352.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Seldon, H. L., J. Siemienowic z, M. Hawso n, P. Steel e, and M. Ibrahi m. "Closing the Communication Gap Between Hospitals and Primary Health Care Providers." Australian Journal of Primary Health 6, no. 4 (2000): 91. http://dx.doi.org/10.1071/py00040.

Full text

Abstract:

Most of the technological attention in health care communications has been given to hospital systems. We perceive a gap in communications between different layers of the health care hierarchy, which often means that relevant information does not accompany patients as they move into or out of hospitals. In this paper we first review some systems, such as HealthLink in New Zealand and Health.On.Net in South Australia, which have been or are being established to rectify this situation. We review systems being developed and installed in our own regions. Planning has involved local hospitals, general practitioners, government, and allied health professionals. Funding has been a major problem, partly due to a lack of defined responsibility for this area. On the technical side, we have opted for the World Wide Web (WWW) communications protocols as the most general and widely accepted; also, the standards for text-based messages (HL7) and for images (DICOM 3.0) are lagging the WWW in capabilities. The communications medium must include normal telephone lines (PSTN or POTS), as these are the connections which most private healthcare providers have. Various forms of security, encryption and access control have been employed. Possibly least important nowadays is the selection of a 'hardware or operating platform'.

APA, Harvard, Vancouver, ISO, and other styles

38

Neale, Jenny, and Aliitasi Tavila. "Evaluating a community initiative with a focus on Indigenous health." Evaluation Journal of Australasia 7, no. 2 (2007): 31–39. http://dx.doi.org/10.1177/1035719x0700700205.

Full text

Abstract:

Porirua Healthlinks Trust, a community organization in the Greater Wellington area, has been mounting an annual ‘Creek Fest’ since 2004. This is a one-day event that focuses on health and culture. It has become increasingly successful particularly in attracting large numbers of Pacific and Maori peoples who live in the immediate locality as well as those from further away. The fest held in March 2006 was evaluated to determine whether it was meeting its stated objectives and what else the organization might do to achieve its health-related goals with regard to this initiative. Of the 500 questionnaires handed out on the day, nearly 400 were completed for analysis. This article draws on both the results of the survey and the process used to report on the evaluation of the fest. The self-administered questionnaire with interviewer-assisted delivery was seen to be the key to obtaining such a high response rate. Implications for undertaking evaluations in ethnically diverse communities are discussed.

APA, Harvard, Vancouver, ISO, and other styles

39

Martin, Carmel, Keith Stockman, Narelle Hinkley, and Donald Campbell. "Multimorbidity and Acute Potentially Preventable Diagnoses in HealthLinks Chronic Care (HLCC) Dandenong Cohort. A work in evolution." International Journal of Integrated Care 20, no. 3 (2021): 173. http://dx.doi.org/10.5334/ijic.s4173.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Dixon, Padraig, Sandra Hollinghurst, Roberta Ara, Louisa Edwards, Alexis Foster, and Chris Salisbury. "Cost-effectiveness modelling of telehealth for patients with raised cardiovascular disease risk: evidence from a cohort simulation conducted alongside the Healthlines randomised controlled trial." BMJ Open 6, no. 9 (2016): e012355. http://dx.doi.org/10.1136/bmjopen-2016-012355.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Yeung, Matthew E. M., Colin G. Weaver, Kevin Janz, Rebecca Haines-Saah, and Eddy Lang. "Clearing the air: A study of cannabis-related presentations to urban Alberta emergency departments following legalization." CJEM 22, no. 6 (2020): 776–83. http://dx.doi.org/10.1017/cem.2020.384.

Full text

Abstract:

ABSTRACTObjectivesNon-medical cannabis recently became legal for adults in Canada. Legalization provides opportunity to investigate the public health effects of national cannabis legalization on presentations to emergency departments (EDs). Our study aimed to explore association between cannabis-related ED presentations, poison control and telemedicine calls, and cannabis legalization.MethodsData were collected from the National Ambulatory Care Reporting System from October 1, 2013, to July 31, 2019, for 14 urban Alberta EDs, from Alberta poison control, and from HealthLink, a public telehealth service covering all of Alberta. Visitation data were obtained to compare pre- and post-legalization periods. An interrupted time-series analysis accounting for existing trends was completed, in addition to the incidence rate ratio (IRR) and relative risk calculation (to evaluate changes in co-diagnoses).ResultsAlthough only 3 of every 1,000 ED visits within the time period were attributed to cannabis, the number of cannabis-related ED presentations increased post-legalization by 3.1 (range -11.5 to 12.6) visits per ED per month (IRR 1.45, 95% confidence interval [CI]; 1.39, 1.51; absolute level change: 43.5 visits per month, 95% CI; 26.5, 60.4). Cannabis-related calls to poison control also increased (IRR 1.87, 95% CI; 1.55, 2.37; absolute level change: 4.0 calls per month, 95% CI; 0.1, 7.9). Lastly, we observed increases in cannabis-related hyperemesis, unintentional ingestion, and individuals leaving the ED pre-treatment. We also observed a decrease in co-ingestant use.ConclusionOverall, Canadian cannabis legalization was associated with small increases in urban Alberta cannabis-related ED visits and calls to a poison control centre.

APA, Harvard, Vancouver, ISO, and other styles

42

Ferrier, Denise, Donald Campbell, Chris Hamilton, et al. "Co-designing a new approach to delivering integrated services to chronically ill patients within existing funding constraints – Victoria’s HealthLinks trial." International Journal of Integrated Care 19, no. 4 (2019): 322. http://dx.doi.org/10.5334/ijic.s3322.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Martin, Carmel, Narelle Hinkley, Keith Stockman, and Donald Campbell. "Capitated Telehealth Coaching Hospital Readmission Service in Australia: Pragmatic Controlled Evaluation." Journal of Medical Internet Research 22, no. 12 (2020): e18046. http://dx.doi.org/10.2196/18046.

Full text

Abstract:

Background MonashWatch is a telehealth public hospital outreach pilot service as a component of the Government of Victoria’s statewide redesign initiative called HealthLinks: Chronic Care. Rather than only paying for hospitalizations, projected funding is released earlier to hospitals to allow them to reduce hospitalization costs. MonashWatch introduced a web-based app, Patient Journey Record System, to assess the risk of the journeys of a cohort of patients identified as frequent admitters. Telecare guides call patients using the Patient Journey Record System to flag potential deterioration. Health coaches (nursing and allied health staff) triage risk and adapt care for individuals. Objective The aim was a pragmatic controlled evaluation of the impact of MonashWatch on the primary outcome of bed days for acute nonsurgical admissions in the intention-to-treat group versus the usual care group. The secondary outcome was hospital admission rates. The net promoter score was used to gauge satisfaction. Methods Patients were recruited into an intention-to-treat group, which included active telehealth and declined/lost/died groups, versus a systematically sampled (4:1) usual care group. A rolling sample of 250-300 active telehealth patients was maintained from December 23, 2016 to June 23, 2019. The outcome—mean bed days in intervention versus control—was adjusted using analysis of covariance for age, gender, admission type, and effective days active in MonashWatch. Time-series analysis tested for trends in change patterns. Results MonashWatch recruited 1373 suitable patients who were allocated into the groups: usual care (n=293) and intention-to-treat (n=1080; active telehealth: 471/1080, 43.6%; declined: 485, 44.9%; lost to follow-up: 178 /1080, 10.7%; died: 8/1080, 0.7%). Admission frequency of intention-to-treat compared to that of the usual care group did not significantly improve (P=.05), with a small number of very frequent admitters in the intention-to-treat group. Age, MonashWatch effective days active, and treatment group independently predicted bed days. The analysis of covariance demonstrated a reduction in bed days of 1.14 (P<.001) in the intention-to-treat group compared with that in the usual care group, with 1236 bed days estimated savings. Both groups demonstrated regression-to-the-mean. The downward trend in improved bed days was significantly greater (P<.001) in the intention-to-treat group (Sen slope –406) than in the usual care group (Sen slope –104). The net promoter score was 95% in the active telehealth group compared with typical hospital scores of 77%. Conclusions Clinically and statistically meaningful reductions in acute hospital bed days in the intention-to-treat group when compared to that of the usual care group were demonstrated (P<.001), although admission frequency was unchanged with more short stay admissions in the intention-to-treat group. Nonrandomized control selection was a limitation. Nonetheless, MonashWatch was successful in the context of the HealthLinks: Chronic Care capitation initiative and is expanding.

APA, Harvard, Vancouver, ISO, and other styles

44

Mewton, Nathan, Cyrille Bergerot, and Catherine Cornu. "Letter by Mewton et al Regarding Article, “Validity of Cardiovascular Data From Electronic Sources: The Multi-Ethnic Study of Atherosclerosis and HealthLNK”." Circulation 137, no. 16 (2018): 1759–60. http://dx.doi.org/10.1161/circulationaha.117.032045.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Ahmad, Faraz S., Cheeling Chan, Marc B. Rosenman, et al. "Response by Ahmad et al to Letter Regarding Article, “Validity of Cardiovascular Data From Electronic Sources: The Multi-Ethnic Study of Atherosclerosis and HealthLNK”." Circulation 137, no. 16 (2018): 1761–62. http://dx.doi.org/10.1161/circulationaha.117.032881.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Ho, Kendall, Helen Novak Lauscher, Kurtis Stewart, et al. "Integration of virtual physician visits into a provincial 8-1-1 health information telephone service during the COVID-19 pandemic: a descriptive study of HealthLink BC Emergency iDoctor-in-assistance (HEiDi)." CMAJ Open 9, no. 2 (2021): E635—E641. http://dx.doi.org/10.9778/cmajo.20200265.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Raad, Jason H., Elizabeth Tarlov, Abel N. Kho, and Dustin D. French. "Health Care Utilization Among Homeless Veterans in Chicago." Military Medicine 185, no. 3-4 (2019): e335-e339. http://dx.doi.org/10.1093/milmed/usz264.

Full text

Abstract:

Abstract Introduction The U.S. Department of Veterans Affairs (VA), the single largest health care system in the United States, provides comprehensive medical and behavioral health services to more than 9 million Veterans. The size and scope of the VA’s system of care allow health care providers, policymakers, and community stakeholders to conduct detailed analyses of health care utilization among Veterans; however, these analyses do not include health care encounters that occur outside VA. Although many Veterans obtain care in non-VA settings, understanding health care utilization among vulnerable populations of Veterans, including those who are homeless or at risk of becoming homeless, is needed to identify potential opportunities to enhance access and reduce fragmentation of care. Materials and Methods VA administrative data were merged with data from the Chicago HealthLNK Data Repository to identify Veterans eligible for VA services who were homeless, or at risk of becoming homeless, in the greater Chicago metropolitan area for the years 2010–2012. Results During the 3-year study period, about 208,554 Veterans were registered for care at two VA medical centers located in the City of Chicago and an adjacent suburb. Of those, 13,948 were identified as homeless or at risk of becoming homeless. Results suggest that 17% (n = 2,309) of Veterans in this sample received some or all of their care in the community. Much of the care these Veterans received was for chronic health conditions, substance use, and mental health disorders. Conclusions Veterans eligible for VA servicers who are homeless, or at risk of becoming homeless, frequently sought care in the community for a variety of chronic health conditions. Health information exchanges and partner-based registries may represent an important tool for identifying vulnerable Veteran populations while reducing duplication of care.

APA, Harvard, Vancouver, ISO, and other styles

48

Yeung, M., C. Weaver, E. Lang, R. Saah-Haines, and K. Janz. "MP03: Clearing the air: A retrospective cohort study of cannabis-related harms in urban Alberta emergency departments following legalization." CJEM 22, S1 (2020): S43. http://dx.doi.org/10.1017/cem.2020.151.

Full text

Abstract:

Introduction: Non-medical cannabis recently became legal on October 18th, 2018 to Canadian adults. The impact of legalization on Emergency Departments (EDs) has been identified as a major concern. The study objective was to identify changes in cannabis-related ED visits and changes in co-existing diagnoses associated with cannabis-related ED visits pre- and post-legalization for the entire urban population of Alberta. Urban Alberta was defined as Calgary and Edmonton, inclusive of Sherwood Park and St. Albert given the proximity of some Edmontonians to their EDs) encompassing 12 adult EDs and 2 pediatric EDs. Methods: Retrospective data was collected from the National Ambulatory Care Reporting System, and from the HealthLink and the Alberta Poison and Drug Information Service (PADIS) public telehealth call databases. An interrupted time-series analysis was completed via segmented regression calculation in addition to incident rate and relative risk ratio calculation for the pre- and post-legalization periods to identify both differences among the entire urban Alberta population and differences among individuals presenting to the ED. Data was collected from October 1st, 2013 up to July 31st, 2019 for ED visits and was adjusted for natural population increase using quarterly reports from the Government of Alberta. Results: The sample included 11 770 pre-legalization cannabis-related visits, and 2962 post-legalization visits. Volumes of ED visits for cannabis-related harms were found to increase post-legalization within urban EDs (IRR 1.45, 95% CI 1.39, 1.51; absolute level change: 43.48 visits per month in urban Alberta, 95% CI 26.52, 60.43), and for PADIS calls (IRR 1.87, 95% CI 1.55, 2.37; absolute level change: 4.02 calls per month in Alberta, 95% CI 0.11, 7.94). The increase in visits to EDs equates to an increase of 2.72 visits per month, per ED. Lastly, increases were observed for cannabinoid hyperemesis (RR 1.23, 95% CI 1.10, 1.36), unintentional ingestion (RR 1.48, 95% CI 1.34, 1.62), and in individuals leaving the ED pre-treatment (RR 1.28, 95% CI 1.08, 1.49). Decreases were observed for coingestant use (RR 0.77, 95% CI 0.73, 0.81) and hospital admissions (RR 0.88, 95% CI 0.80, 0.96). Conclusion: Overall, national legalization of cannabis appears to be correlated with a small increase in cannabis-related ED visits and poison control calls. Post-legalization, fewer patients are being admitted, though cannabinoid hyperemesis appears to be on the rise.

APA, Harvard, Vancouver, ISO, and other styles

49

Vanderkooi, Otto G., Jianling Xie, Bonita Lee, et al. "Gastroenteritis Severity: A Prospective Cohort Comparison of Children in Emergency Department and Home Settings." Open Forum Infectious Diseases 4, suppl_1 (2017): S363. http://dx.doi.org/10.1093/ofid/ofx163.883.

Full text

Abstract:

Abstract Background While nearly 2 million children are brought to emergency department (ED) annually due to vomiting and/or diarrhea from acute gastroenteritis (AGE), it is estimated that 90% of AGE cases do not seek medical care. We sought to determine whether the disease severity and enteropathogen burden of disease of children with AGE brought for ED care is different from those cared for at home. Methods Subjects were prospectively recruited by the APPETITE team in pediatric EDs in 2 urban centers and via HealthLink, a province-wide nurse telephone advice line. Eligibility criteria included: < 18 years old, AGE defined by ≥ 3 episodes of vomiting or diarrhea in the preceding 24 hours, and < 7 days of symptoms. The primary outcome was index encounter disease severity quantified using the modified Vesikari Scale (MVS) score. To eliminate the impact of the index encounter on the score we excluded the index ED visit and intervention from all calculations. Secondary objectives included the enteropathogen burden of disease. Two rectal swabs and stool were collected and tested for enteropathogens by enteric bacterial culture, Luminex xTAG GPP, and a 5-virus in-house RT-qPCR panel. Results Between December 9, 2014 and December 31, 2016, 1,623 participants were enrolled with 81.5% from the EDs. Median age was 20.1 months. Children who went to ED were less likely to have a family physician (62 vs. 82%, P < 0.001), more likely to have clinical dehydration (Clinical Dehydration Scale score 3 vs 1, P < 0.001) and vomiting (91 vs. 85%, P = 0.004), previously received IV fluids (4.1 vs. 0.7%, P = 0.001) or been admitted (5.4 vs. 1.3%, P = 0.002). The MVS score was similar between groups when the contribution of the index visit to the score was excluded (8.1 vs. 7.8, P = 0.15). Participants recruited in the ED were not significantly more likely to have bacterial pathogens (8.0 vs. 3.7%, P = 0.09) but were less likely to have viral pathogens identified (64.1 vs. 80.7, P < 0.001). Conclusion Children presenting for ED care had disease severity scores that were similar to children managed at home when the contribution of the index ED visit was accounted for. Viral pathogens were more common in AGE receiving care at home while those presenting to the ED and potentially have a clinically greater likelihood of having a bacterial enteropathogen. Disclosures All authors: No reported disclosures.

APA, Harvard, Vancouver, ISO, and other styles

50

Thompson, Caroline A., and Ming-Hsiang Tsou. "Abstract IA08: Improving researcher accessibility to publicly available data through creative integration, geospatial visualization, and open data portals." Cancer Epidemiology, Biomarkers & Prevention 29, no. 9_Supplement (2020): IA08. http://dx.doi.org/10.1158/1538-7755.modpop19-ia08.

Full text

Abstract:

Abstract The increased accessibility of population-level data made available by the government and public health and consumer agencies provides a unique opportunity for integrative data analysis, spatial visualization with much higher resolution to identify clusters of disease, and their correlation with geospatial, socioeconomic, and demographic predictors. However, interactive mapping and spatial analysis tools are underutilized by health researchers and decision-makers as a result of scarce training materials, few examples demonstrating their successful use, and poor mechanisms for sharing results generated by geovisualization. Further, in the wake of massive amounts of new data and analytical tool availability, consumers of cancer population health data, such as academic researchers and public health practitioners, are facing an ongoing transformation of practice resulting in the need for effective collaboration and sharing of resources within and across disciplinary and geographic boundaries. In this talk we will summarize three of our ongoing projects that leverage web-based technologies with the aim to reduce barriers to data sharing, promote simultaneous analysis of multiple datasets, and enable geovisualization of cancer outcomes and their interrelationships with social and spatial factors. The Disentangling Disparities Data Warehouse, or D3W, is a population-based data resource that includes geotagged California Cancer Registry data linked to census, American Community Survey, and other curated sources of neighborhood-level contextual and environmental data. The D3W allows ecologic and/or multilevel statistical analysis and supports sophisticated analysis of the spatial dynamics of cancer in California. The HealthWebMapper is a highly interactive data visualization tool with a simple two-tier web geographic information systems (GIS) framework. This dynamic web GIS/mapping tool was created with open-source JavaScript library, Leaflet, and free web authoring tools (bootstrap, jquery, and Google Chart) to provide user-friendly maps and data-mining functions, including multiple classification methods, correlation analysis, data export, and side-by-side displays. HealthWebMapper is an open source application and available via a public Github repository, and it can be easily installed on any website without specialized GIS servers or databases. Finally, to promote ease of access to the D3W and HealthWebMapper as well as other research data resources, we are developing the Health Data Open Analytic Portal, with support from the newly established NIH-funded HealthLINK Center for Population Health and Health Disparities Research at San Diego State University. The key functions of the open data portal are to archive, manage, download, and integrate disease, environmental, socioeconomic, and health behavior data. The data portal will enable the sharing, archiving, and learning of research procedures and health data resources. The searchable and downloadable data portal will also provide comprehensive research investigator profiles and online training materials to facilitate transdisciplinary research collaborations in cancer population health and beyond. Citation Format: Caroline A. Thompson, Ming-Hsiang Tsou. Improving researcher accessibility to publicly available data through creative integration, geospatial visualization, and open data portals [abstract]. In: Proceedings of the AACR Special Conference on Modernizing Population Sciences in the Digital Age; 2019 Feb 19-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(9 Suppl):Abstract nr IA08.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!